库拉肿瘤

最新新闻

• 评级变动
  H.C. Wainwright Maintains Kura Oncology(KURA.US) With Buy Rating, Maintains Target Price $40
  \u5e02\u573a\u8d44\u8baf · 2026/9/9
• 公司公告
  Speee: Secret remittance demo "Kura Pay" and the beta version of "KuraPrivacy Service API" are now available.
  JPX · 2026/7/29
• William Blair Maintains Kura Sushi USA(KRUS.US) With Buy Rating
  \u5e02\u573a\u8d44\u8baf · 2026/9/23
• 评级变动
  A Quick Look at Today's Ratings for Kura Oncology(KURA.US), With a Forecast Between $28 to $40
  \u5e02\u573a\u8d44\u8baf · 2026/8/13
• 评级变动
  BofA Securities Maintains Kura Oncology(KURA.US) With Buy Rating, Maintains Target Price $30
  \u5e02\u573a\u8d44\u8baf · 2026/7/22
• 评级变动
  Wedbush Maintains Kura Oncology(KURA.US) With Buy Rating, Raises Target Price to $36
  \u5e02\u573a\u8d44\u8baf · 2026/7/29
• 公司公告
  Kura Oncology | 4: Statement of changes in beneficial ownership of securities-Officer Powl Brian T.
  SEC · 2026/5/23
• 评级变动
  Barclays Maintains Kura Oncology(KURA.US) With Buy Rating, Maintains Target Price $28
  \u5e02\u573a\u8d44\u8baf · 2026/9/10
• 评级变动
  Lake Street Maintains Kura Oncology(KURA.US) With Buy Rating, Maintains Target Price $23
  \u5e02\u573a\u8d44\u8baf · 2026/9/10
• 评级变动
  Kura Sushi, Inc. (2695) Receives a Hold From Mizuho Securities
  TipRanks · 2026/9/16
• BofA Securities Maintains Kura Oncology(KURA.US) With Buy Rating, Maintains Target Price $31
  \u5e02\u573a\u8d44\u8baf · 2026/9/30
• J.P. Morgan Initiates Kura Oncology(KURA.US) With Buy Rating, Announces Target Price $30
  \u5e02\u573a\u8d44\u8baf · 2026/10/1
• 公司公告
  4: Kura Oncology | 4: Statement of changes in beneficial ownership of securities-Director Parks Diane L.
  SEC · 2026/6/5
• SBI Securities Keeps Their Buy Rating on Kura Sushi, Inc. (2695)
  TipRanks · 2026/9/28
• 评级变动
  Mizuho Securities Maintains Kura Oncology(KURA.US) With Buy Rating, Maintains Target Price $25
  \u5e02\u573a\u8d44\u8baf · 2026/8/31
• 评级变动
  Craig-Hallum Maintains Kura Sushi USA(KRUS.US) With Buy Rating, Announces Target Price $80
  \u5e02\u573a\u8d44\u8baf · 2026/7/8
• 评级变动
  A Quick Look at Today's Ratings for Kura Oncology(KURA.US), With a Forecast Between $23 to $40
  \u5e02\u573a\u8d44\u8baf · 2026/8/14
• 公司公告
  Commerce One Holdings: We have begun offering a data integration option for the multi-store e-commerce management system "Tsūhan suru Kura" and "TikTok Shop."
  JPX · 2026/7/16
• 公司公告
  Kura Oncology | 4: Statement of changes in beneficial ownership of securities-Officer Powl Brian T.
  SEC · 2026/9/30
• UBS Maintains Kura Oncology(KURA.US) With Buy Rating, Maintains Target Price $15
  \u5e02\u573a\u8d44\u8baf · 2026/8/21

新闻标题为自动聚合内容，未经我们团队独立核实或编辑。